Aims/hypothesis Mitochondria-associated endoplasmic reticulum membranes (MAMs) are regions of the endoplasmic reticulum (ER) tethered to mitochondria and controlling calcium (Ca 2+ ) transfer between both organelles through the complex formed between the voltage-dependent anion channel, glucose-regulated protein 75 and inositol 1,4,5-triphosphate receptor (IP3R). We recently identified cyclophilin D (CYPD) as a new partner of this complex and demonstrated a new role for MAMs in the control of insulin's action in the liver. Here, we report on the mechanisms by which disruption of MAM integrity induces hepatic insulin resistance in CypD (also known as Ppif)-knockout (KO) mice. Methods We used either in vitro pharmacological and genetic inhibition of CYPD in HuH7 cells or in vivo loss of CYPD in mice to investigate ER-mitochondria interactions, inter-organelle Ca 2+ exchange, organelle homeostasis and insulin action. Results Pharmacological and genetic inhibition of CYPD concomitantly reduced ER-mitochondria interactions, inhibited inter-organelle Ca 2+ exchange, induced ER stress and altered insulin signalling in HuH7 cells. In addition, histaminestimulated Ca 2+ transfer from ER to mitochondria was blunted in isolated hepatocytes of CypD-KO mice and this was associated with an increase in ER calcium store. Interestingly, disruption of inter-organelle Ca 2+ transfer was associated with ER stress, mitochondrial dysfunction, lipid accumulation, activation of c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)ε and insulin resistance in liver of CypD-KO mice. Finally, CYPD-related alterations of insulin signalling were mediated by activation of PKCε rather than JNK in HuH7 cells. Conclusions/interpretation Disruption of IP3R-mediated Ca 2+ signalling in the liver of CypD-KO mice leads to hepatic insulin resistance through disruption of organelle interaction and function, increase in lipid accumulation and activation of PKCε. Modulation of ER-mitochondria Ca 2+ exchange may thus provide an exciting new avenue for treating hepatic insulin resistance.
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Introduction
Mitochondria and endoplasmic reticulum (ER) are organised as a network with specific contact points, referred to as mitochondrial-associated ER membranes (MAMs), which play a pivotal role in calcium (Ca
2+
) signalling and energy metabolism [1] . Efficient Ca 2+ transmission from the ER to mitochondria is mediated through the interaction of the voltage-dependent anion channel (VDAC) of the outer mitochondrial membrane with the inositol-1,4,5-triphosphate receptor (IP3R) on the ER via the chaperone glucose-regulated protein 75 (GRP75) [2] . Mitochondrial Ca 2+ uptake is essential for the regulation of both mitochondrial metabolism and ER homeostasis [3] , and alteration of ER-mitochondria crosstalk may result in a disruption of inter-organelle Ca 2+ transfer [4] and subsequent ER stress [5] . Under certain conditions excessive Ca 2+ entry into the mitochondrial matrix may be detrimental, causing the opening of the permeability transition pore (PTP) and cell death [6] . Therefore, tight control of Ca 2+ exchange between ER and mitochondria is required to regulate vital functions and metabolic homeostasis.
The molecular and functional characterisation of MAMs in physiological and pathological conditions has improved in the last few years, highlighting unexpected roles for MAMs in cellular signalling [7] . Particularly, we recently demonstrated that cyclophilin D (CYPD), a mitochondrial protein known to modulate the opening of the PTP [8] , also interacts with the VDAC-GRP75-IP3R complex at the MAM interface in both heart [9] and liver [10] . In cardiomyocytes, we found that the loss of CYPD reduced mitochondrial Ca 2+ overload by depressing ER-mitochondria interactions and protected cells against lethal reperfusion injury [9] , suggesting that CYPD regulates Ca 2+ transfer from ER to mitochondria. In liver, the loss of CYPD reduced organelle interactions and induced hepatic insulin resistance, pointing to a new role of MAM integrity in the control of insulin's action [10] . Whereas other studies in mice also suggest a role for MAMs in the control of glucose homeostasis [11] [12] [13] [14] , the mechanisms by which disruption of MAMs alters insulin signalling are unknown.
Based on the role of MAMs in Ca 2+ transfer from ER to mitochondria, we hypothesised that a disruption of Ca 2+ transfer between both organelles could contribute to hepatic insulin resistance. To this aim, using pharmacological and genetic loss of function approaches both in vivo and in vitro, we investigated whether the disruption of Ca 2+ transfer from ER to mitochondria could link MAM alterations to hepatic insulin resistance in CypD (also known as Ppif)-knockout (KO) mice.
Methods
Cell culture HuH7 cells were a gift from G. Mithieux's laboratory (Inserm U855, Lyon, France) and were free of mycoplasma. They were cultured as previously described [10] and stimulated either with CYPD (ciclosporin [cyclosporin A, CsA] or NIM811) or with IP3R (2-APB and Xestospongin C) pharmacological inhibitors. Inhibition of CYPD was also achieved by silencing of CYPD. See electronic supplementary material (ESM) Methods for further details. For measurement of insulin signalling, cells were depleted in serum for 3 h before incubation with insulin (10 −7 mol/l, 15 min).
Animals CYPD-KO mice on a C57Bl/6/SV129 genetic background were a gift from S. J. Korsmeyer's laboratory (Boston, MA, USA) [15] . Both male wild-type (WT) and CYPD-KO mice were obtained by homozygous intercross in our laboratory. All experiments were performed on mice of 18-22 weeks of age, and were conducted in accordance with institutional guidelines for the care and use of laboratory animals, and a regional ethics committee has approved all procedures. No randomisation or blinding were performed. No data samples or animals were excluded from the study.
Ca
2+ measurements Using confocal fluorescence imaging, we evaluated variations in the time course of mitochondrial Ca 2+ content simultaneously with intra-ER Ca 2+ in a native cell environment in the presence of extracellular calcium (1.8 mmol/l CaCl 2 ) [16] . To measure mitochondrial Ca 2+ , cells were loaded with Rhod-2 AM (3 μmol/l) whereas the measurement of ER Ca 2+ was performed using a low-affinity Ca 2+ indicator, Fluo-5N (5 μmol/l; ThermoFisher Scientific, MA, USA). For measurement of absolute cytosolic Ca 2+ levels, cells were loaded with 1 μmol/l of Fura2-AM and pluronic acid (both from ThermoFisher Scientific). See ESM Methods for further details.
ER-mitochondria interactions ER-mitochondria interactions were measured both by subcellular fractionation and by in situ proximity ligation assay (PLA), as previously described and thoroughly validated [10] . See ESM Methods for further details.
Real-time PCR mRNA levels were measured by real-time RT-PCR. See ESM Methods for further details.
Western blotting Protein expression was analysed by SDS-PAGE. See ESM Methods for further details.
Hyperinsulinaemic-euglycaemic clamp Insulin sensitivity of mice was measured during a hyperinsulinaemiceuglycaemic clamp. See ESM Methods for further details.
Primary hepatocytes Primary mouse hepatocytes were isolated via a modified collagenase perfusion method, as described previously [17] . See ESM Methods for further details.
Mitochondrial respiration Mitochondrial respiration was measured in intact or permeabilised primary hepatocytes. See ESM Methods for further details.
Hepatic lipid content Hepatic triacylglycerol (TG) and diacylglycerol (DAG) content were measured by spectrophotometry. See ESM Methods for further details.
PKCε activity PKCε activity in liver was determined by western blot based on the membrane translocation. See ESM Methods for further details.
Statistical analysis Results are expressed as mean ± SEM. Student's t-test was used to analyse the difference between control and experimental groups. Statistically significant differences were assessed with a one-way ANOVA with a Newman-Keuls post hoc test when three or more groups were compared. A p value <0.05 was considered as statistically significant.
Results
Pharmacological and genetic inhibition of CYPD inhibits Ca 2+ transfer from ER to mitochondria in HuH7 cells We recently demonstrated by in situ PLA that CYPD interacted with the VDAC1-GRP75-IP3R1 calcium-channelling complex [9, 10] . Here, we challenged the interactions of CYPD with this complex using pharmacological and genetic loss of function studies, and investigated the repercussions on both ER-mitochondria interactions and Ca 2+ transfer. As CYPD inhibitors we used CsA and NIM811 (a CsA derivative devoid of immunosuppressive activity), which are both known to detach CYPD from the inner mitochondrial membrane [18] . Treatment of HuH7 cells with CsA or NIM811 significantly inhibited CYPD-IP3R1 interactions (Fig. 1a) . Reduction of CYPD expression using specific small interfering RNA (siRNA) (Fig. 1b) also significantly decreased the interactions between CYPD and IP3R1 (Fig. 1c) .
Using organelle-targeted fluorescent dye, we then measured Ca 2+ flux in HuH7 cells under histamine stimulation (100 μmol/l). Histamine binding to its receptor induces inositol-1,4,5-triphosphate elevation and activates IP3R, causing Ca 2+ release from ER stores. Specificity and non-overlapping of the Ca 2+ -sensitive dyes is illustrated in ESM Fig. 1 . Histamine application rapidly reduced ER Ca 2+ stores ( Fig. 2a ) and simultaneously increased mitochondrial Ca 2+ content ( Fig. 2b ), illustrating transfer of Ca 2+ from the ER to the mitochondria. Importantly, after NIM811 treatment or CYPD silencing, histamine was unable to induce Ca 2+ transfer from ER to mitochondria, as illustrated by the absence of mitochondrial Ca 2+ accumulation in both situations (Fig. 2a, b) .
Inhibition of CYPD function induces ER stress and alters insulin response in HuH7 cells Next, we measured the consequences of CYPD inhibition on both ER and mitochondrial homeostasis and on insulin signalling in HuH7 cells. NIM811 treatment significantly increased mRNA levels of GRP78, XBP1S and CHOP (also known as DDIT3) (Fig. 3a) , as well as the protein level of GRP78 and the phosphorylation of eukaryotic translation initiation factor 2α (EIF2α) (Fig. 3b) , indicative of ER stress. However, this treatment had no effect on the mRNA levels of HSP10 and HSP60 (Fig. 3a) , two markers of mitochondrial stress that are increased during the mitochondrial unfolded protein response [19] . Inhibition of CYPD using CsA reproduced the same effects (ESM Fig. 2a, b) . Finally, the partial invalidation of CYPD expression by specific siRNA also induced ER stress markers (Fig. 3c) .
NIM811 treatment also significantly reduced insulinstimulated protein kinase B (PKB) phosphorylation ( Fig. 3d ) and induced PEPCK mRNA expression (ESM Fig. 2c ) in HuH7 cells. Inhibition of CYPD using CsA reproduced all these effects (ESM Fig. 2d , e). In addition, the partial invalidation of CYPD expression by siRNA also altered insulin signalling ( Fig. 3e ) and induced PEPCK expression (ESM Fig. 2f ). To strengthen the link between IP3R-mediated Ca 2+ signalling, ER homeostasis and insulin signalling, we investigated whether pharmacological inhibition of IP3R could alter insulin signalling independently of CYPD. Both 2-APB and Xestospongin C treatments, which antagonise the calciumreleasing action of inositol-1,4,5-trisphosphate at the receptor level, significantly induced ER stress (Fig. 4a, b) and reduced insulin-stimulated PKB phosphorylation (Fig. 4c, d ) in HuH7 cells.
Loss of CYPD in mice alters Ca
2+ transfer from ER to mitochondria in isolated hepatocytes We previously found that ER-mitochondria interactions were reduced in liver of CypD-KO mice [10] . We confirmed in this study our initial observation using an independent group of mice (Fig. 5a ) and further analysed the composition of MAM fractions of WT and CypD-KO mice. We found no significant modification of IP3R1, VDAC1, GRP75, mitofusin 2 (MFN2) or sarco(endo)plasmic reticulum Ca 2+ ATPase 2 (SERCA2) protein level in MAM fractions of CypD-KO mice compared with WT mice (Fig. 5b) . This suggests that loss of CYPD induces a dissociation of organelles rather than a change in MAM protein composition. We then examined inter-organelle Ca 2+ flux in isolated hepatocytes of CypD-KO mice, following the same experimental protocol performed in HuH7 cells. In WT hepatocytes, histamine induced Ca 2+ release from the ER, immediately followed by mitochondrial Ca 2+ uptake (Fig. 5c, d ). This histaminestimulated Ca 2+ transfer from the ER to mitochondria was completely abolished in CypD-KO hepatocytes (Fig. 5c, d ). This occurs in the absence of a modification of Serca2b (also known as Atp2a2) and Mcu mRNA levels in liver of CypD-KO mice (ESM Fig. 3a) . Together, these results confirm in a more physiological model that CYPD participates in IP3-mediated ER-tomitochondria Ca 2+ transfer in hepatocytes. We also measured cytoplasmic Ca 2+ in response to a discharge of ER store by thapsigargin, both in the presence and absence of extracellular Ca 2+ . In both conditions, thapsigargin-sensitive Ca 2+ stores were significantly higher in CypD-KO mice compared with WT mice (Fig. 5e, f indicating that the reduced Ca 2+ transfer from ER to mitochondria in CypD-KO hepatocytes was not due to a defect of ER Ca 2+ storage. In addition, resting cytosolic Ca 2+ was significantly increased in CypD-KO hepatocytes in the presence of extracellular Ca 2+ , whereas this effect was absent in the absence of extracellular Ca 2+ (ESM Fig. 3b, c) . The cytosolic Ca 2+ peak after histamine stimulation did not differ significantly between WT and CypD-KO mice, in either the presence or absence of extracellular Ca 2+ (ESM Fig. 3d ).
Loss of CYPD in mice induces ER stress and mitochondrial dysfunction in liver We then investigated ER or mitochondrial stress markers in the liver of WT and CypD-KO mice. We found increased mRNA levels of Grp78 and Chop in the liver of CypD-KO mice, without any change in Hsp10 and Hsp60 expression (Fig. 6a) . In addition, the phosphorylation of PERK, EIF2α and of JNK (a serine/threonine kinase involved in ER stress-induced hepatic insulin resistance [20] ) was increased in liver of CypD-KO mice (Fig. 6b) , confirming hepatic ER stress. As Ca 2+ import into mitochondria affects mitochondrial bioenergetics [21, 22] , we studied mitochondrial respiration in either permeabilised (glutamate/malate) or intact (20 mmol/ l glucose) primary hepatocytes of both WT and CypD-KO mice, in order to maintain ER mitochondria cross-talk. As shown in Fig. 6c, d , oxygen consumption was significantly reduced in CypD-KO hepatocytes, compared with WT hepatocytes.
Loss of CYPD in mice increases lipid accumulation and PKC activity and induces hepatic insulin resistance We previously reported that CypD-KO mice are glucose intolerant, insulin resistant and showed increased gluconeogenesis, based on tolerance tests [10] . Here, we further performed hyperinsulinaemic-euglycaemic clamp to confirm hepatic insulin resistance. The glucose infusion rate required to maintain euglycaemia was significantly lower in CypD-KO mice compared with that in WT mice (Fig. 7a) . In addition, the suppression of hepatic glucose production was significantly reduced in CypD-KO mice (Fig. 7b) , whereas peripheral glucose utilisation was unaltered (Fig. 7a) , indicating a specific state of hepatic insulin resistance. In agreement, the expression levels of gluconeogenic enzymes were increased in liver of CypD-KO mice (Fig. 7c) .
We also examined lipid metabolism in both WT and CypD-KO mice. Circulating NEFA were not modified in CypD-KO mice compared with WT mice (0.19±0.05 vs 0.16±0.05 mmol/l, respectively, n=10), whereas blood TG levels were significantly increased (0.90 ±0.03 vs 0.60±0.05 g/l, respectively, p<0.05, n=10). Interestingly, the lipid staining (Fig. 7d) , as well as TG and total DAG levels ( Fig. 7e) , were significantly increased in the liver of CypD-KO mice. As PKCε was shown to be involved in DAG-mediated hepatic insulin resistance [23] , we analysed its activity by measuring its translocation from cytosol to membrane. Consistent with DAG accumulation, PKCε activity was induced in the livers of CypD-KO mice (Fig. 7f) . Furthermore, the mRNA levels of genes related to β-oxidation (Cpt1a) were decreased in liver of CypD-KO mice, whereas the expression of both lipogenic genes (Srebp1c [also known as Srebf1], Srebp1a, Fasn, Acaca) and genes involved in lipid export (Apob, Mttp) were increased (Fig. 7g) . The expression of neither Mlycd nor Dgat2 was modified in liver of CypD-KO mice compared with WT mice. Altogether, these results suggest that lipid accumulation in liver of CypD-KO mice is likely related to both a mice. Experiments and presentation of the results are as described in Fig. 2 . *p<0.05 for CypD-KO vs WT (n=12). (e, f) Representative curves (e) and quantitative analysis (f) of cytosolic Ca 2+ (Fura2), following depletion of ER Ca 2+ storage by thapsigargin (Thapsi.; 10 μmol/l), in the presence (1.8 mmol/l CaCl 2 ) or absence (5 mmol/l EGTA) of extracellular Ca 2+ in WT (black curve and white bars) and CypD-KO (grey curve and grey bars) mice. *p<0.01 and **p<0.001 for indicated comparisons (n= [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] reduction in lipid oxidation and an increase in lipid storage, the latter being mainly associated with increased de novo lipogenesis.
Role of PKCε in CYPD-related alteration of insulin signalling Both JNK and PKCε enzymes, which are increased in liver of CypD-KO mice, are potential mediators of hepatic insulin resistance [20, 23] . To discriminate between the two, we measured the effect of CYPD silencing on insulinstimulated PKB phosphorylation in the presence or absence of JNK and PKCε inhibitors. Inhibition of JNK with SP600125 did not modify CYPD siRNA-induced alteration of insulinstimulated PKB phosphorylation (Fig. 8a) , whereas inhibition of PKCε activity, using a specific peptide inhibitor of PKCε, prevented the reduction of insulin-stimulated PKB phosphorylation induced by CYPD silencing in HuH7 cells (Fig. 8b) . Together, these data suggest a predominant role for PKCε, rather than JNK, in CYPD-related alterations of insulin signalling, at least in vitro.
Discussion
Hepatic insulin resistance is a principal component of type 2 diabetes, but the cellular and molecular mechanisms responsible for its pathogenesis are only partly known. We recently proposed a role for MAM integrity in the control of hepatic insulin action and demonstrated that disruption of MAM integrity in the liver of CypD-KO mice can induce hepatic insulin resistance [10] . In the present study, we further investigated the underlying mechanisms and showed that the disruption of Ca
2+
transfer from ER to mitochondria in the liver of CypD-KO mice is likely the molecular consequence of MAM disruption, accounting for defective insulin action in the liver. ER-mitochondria contact points are known to be enriched in Ca 2+ -handling proteins and chaperones and to generate microdomains with a high Ca 2+ concentration [3] . We provide in vivo and in vitro evidence that pharmacological or genetic inhibition of the mitochondrial chaperone CYPD results in modifications of ER-mitochondria Ca 2+ transfer: (1) via CYPD binding to the mitochondrial inner membrane since its actions are inhibited by CsA and NIM811 and (2) via an interaction with the VDAC1-GRP75-IP3R1 Ca 2+ -channelling complex. These data are consistent with our recent study demonstrating that inhibition of CYPD in cardiomyocytes decreased the Ca 2+ transfer from ER to mitochondria through IP3R under normoxic conditions [9] . Furthermore, CYPD-mediated disruption of ER-mitochondria cross-talk seems related rather to a dissociation of organelle than to a modification of protein expression at MAM interface, and seems independent of a modification of both Mcu and Serca2b mRNA levels. This new physiological role of CYPD in ER-mitochondria communication should now be considered as clinically relevant because inhibitors of CYPD function are either already used in clinical practice (e.g. CsA in transplanted patients) or are being developed (e.g. for treatment of hepatitis C virus or HIV infections) [24] .
Our findings also point to a fundamental mechanism by which reduced structural and functional ER-mitochondria interactions alter organelle function and subsequently inhibit insulin's action, leading to hepatic insulin resistance. We thus propose a model by which the loss of CYPD can induce liver insulin resistance (Fig. 8c) . Invalidation of CYPD alters ERmitochondria interactions and Ca 2+ exchange, leading to increased ER Ca 2+ storage and ER stress. It is likely that the loss of CYPD-mediated uncoupling of the ER from the mitochondria is compensated by increased levels of the ER proteinfolding machinery and Ca 2+ to re-establish ER homeostasis, as previously reported [4, 5, 21] . At the same time, lack of Ca 2+ transfer to mitochondria in CypD-KO mouse hepatocytes can reduce mitochondrial respiration, as also seen in a recent study demonstrating that constitutive low-level IP3R-mediated Ca 2+ delivery to mitochondria is essential to maintain normal cellular bioenergetics [22] . The chronic disturbance of Ca 2+ homeostasis likely maintains the activation of unfolded protein response in liver of CypD-KO mice, despite increased GRP78 expression. Subsequently, both ER stress and mitochondrial dysfunction may contribute to an increase in hepatic lipid levels. Indeed, fat accumulation in the liver of CypD-KO mice seems to be related to both a reduction in lipid oxidation (based on reduction in Cpt1 expression) and an induction of de novo lipogenesis (based on induction of lipogenic genes), whereas esterification of lipid (based on the absence of change in circulating NEFA levels) and export of lipids (based on induction of ApoB and Mttp genes) from liver should not be altered. The induction of de novo lipogenesis is in agreement with the activation of both PERK and IRE1 branches of the unfolded protein response in the liver of CypD-KO mice, as both pathways were shown to activate the lipogenic transcription factor SREBP-1c [25] [26] [27] . Particularly, accumulation of DAG likely contributes to PKCε activation in the liver of CypD-KO mice. Together, these metabolic stresses would consequently result in alterations of hepatic insulin signalling and in the deterioration of glucose homeostasis in CypD-KO mice. Indeed, both induction of ER stress and accumulation of intracellular lipids have been involved in hepatic insulin resistance. Activation of JNK has been shown in ER stress-mediated hepatic insulin resistance [20] and activation of PKCε has been related to DAG-induced hepatic insulin resistance [23] . In CypD-KO mice, hepatic insulin resistance appears to be mainly secondary to ER stress modulation of hepatic lipogenesis and subsequent DAG-mediated activation of PKCε rather than to ER stressinduced JNK activation, at least in vitro. Whereas an unspecific effect of inhibitors could not be excluded, this result fits well with the mechanisms recently proposed for another mouse model of insulin resistance [28] , as well as with recent data in human liver [23] . Nevertheless, we cannot exclude the possibility that other players could be involved in the insulinresistant phenotype of CypD-KO mice. Particularly, as absolute cytosolic Ca 2+ levels were increased in CypD-KO mouse hepatocytes, we cannot exclude the participation of Ca 2+ -sensitive kinases and/or phosphatases in the alteration of insulin signalling, as suggested by others studies [29, 30] . As disruption of MAM integrity has been observed in liver of different mouse models of obesity and type 2 diabetes [10] , it is likely that the unexpected role of inter-organelle Ca 2+ exchange in triggering hepatic insulin resistance might be extrapolated to these models. In agreement, the direct inhibition of IP3R, independently of CYPD, also induced ER stress and altered hepatic insulin signalling, suggesting that the proposed mechanism is a more general model and not restricted to the CypD-KO mouse model. Nevertheless, as controversy exists in this topic [31] , further studies are required to clarify the role of inter-organelle Ca 2+ exchange in triggering hepatic insulin resistance in obesity.
In conclusion, our data demonstrate that CYPD is an important regulator of MAM integrity and subsequently of Ca 2+ exchange at the MAM interface, and provide the first evidence that IP3R-mediated Ca 2+ transfer from ER to mitochondria is an essential cellular process involved in the control of hepatic insulin action. Therefore, modulation of ER-mitochondria Ca 2+ exchange may provide an exciting new avenue for treating hepatic insulin resistance.
